Criteria of drug risk management decision in thailand
- At: 2014 FIP Congress in PSWC, Melbourne (Australia)
- Type: Poster
- By: SRIPHIROMYA, Pakawadee (Chulalongkorn University, Social Administration Pharmacy, Bangkok, Thailand)
- Co-author(s): Wechwithan, Sareeya (MINISTRY OF PUBLIC HEALTH, Bangkok, Thailand)
Background: The drug risk management (DRM) system in Thailand has performed in various methods. In post marketing phase, the regulatory decision is decided after benefit and risk assessment from the Drug Safety Advisory subcommittee of Thai Food and Drug Administration (Thai FDA). Some new box or legal warnings were issued after drug marketing.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.